Transforming growth factor-β1: A possible signal molecule for posthemorrhagic hydrocephalus?

Pediatric Research

Volumn 46, Issue 5, 1999, Pages 576-580

  Whitelaw, Andrew ^a   Christie, Sue ^b   Pople, Ian ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICLE DILATATION; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HYDROCEPHALUS; IMMUNOASSAY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

EID: 0032727746     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199911000-00014     Document Type: Article

References (28)

1. Hill AH, Shackleford GD, Volpe JJ 1985 A potential mechanism for pathogenesis for early post-haemorrhage hydrocephalus in the premature newborn. Pediatrics 73:19-21
2. Larroche JC 1972 Posthaemorrhagic hydrocephalus in infancy. Biol Neonatorum 20:287-299
3. Pang D, Sclabassi RJ, Horton JA 1986 Lysis of intraventricular clot with urokinase in a canine model: 3. effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553-572
4. Brinker T, Seifert V, Dietz H 1992 Subacute hydrocephalus after experimental subarachnoid hemorrhage: its prevention by intrathecal fibrinolysis with recombinant tissue plasminogen activator. Neurosurgery 31:306-312
5. Whitelaw A, Creighlon L, Gaffney P 1991 Fibrinolytic activity in cerebrospinal fluid after intraventricular haemorrhage. Arch Dis Child 66:808-809
6. Whitelaw A 1993 Endogenous fibrinolysis in neonatal cerebrospinal fluid. Eur J Pediatr 152:928-930
7. Whitelaw A, Mowinckel MC, Larsen M, Røkas E, Abildgaard U 1994 Intraventricular streptokinase increases cerebrospinal D dimer in preterm infants with posthaemorrhagic ventricular dilation. Acta Paediatr 83:270-272
8. Whitelaw A, Mowinckel MC, Fellman V, Abildgaard U 1996 Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid. Eur J Pediatr 155:117-119
9. Whitelaw, A, Saliba E, Fellman V, Mowinckel M-C, Acolet D, Marlow NA 1996 A phase 1 study of intraventricular recombinant tissue plasminogen activator for the treatment of posthaemorrhagic hydrocephalus. Arch Dis Child Fetal Neonatal Ed75:F20-26
10. Hansen AR, Volpe JJ, Goumnerova LC, Madsen JR 1997 Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Pediatr Neurol 17:213-217
11. Hudgins RJ, Boydston WR, Hudgins PA, Morris R, Adler SM, Gilreath CL 1997 Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant. Pediatr Neurosurg 26:281-287
12. Luciano R, Velardi F, Romagnoli C, Papacci P, DeStefano V, Tortorolo G 1997 Failure of fibrinolytic endoventricular treatment to prevent neonatal posthaemorraghic hydrocephalus. Childs Nerv Syst 13:73-76
13. Ignotz RA, Massague J 1986 Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345
14. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefiled LM, Heine UI, Liotta LA, Falanga V, Kehrl JH 1986 Transforming growth factor type β rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171
15. Massague J, Boyd FT, Andres JL, Chefetz S 1990 Mediators of TGF-β action: TGF-β receptors and TGF-β-binding proteoglycans. Ann NY Acad Sci 593:59-72
16. Bennett NT, Schutz GS 1993 Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 165:728-37
17. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Berezney H, Greenberg AH 1991 Increased production and immunohistochemical localization of transforming growth factor-β1 in idiopathic pulmonary fibrosis. Am J Resp Cell Mol Biol 5:155-162
18. Castilla A, Prieto J, Fausto N 1991 Transforming growth factor β-1 and alpha in chronic liver disease: effect of interferon alpha therapy. N Engl J Med 324:933-940
19. Border WA, Ruoslahti E 1990 Transforming growth factor β-1 induces extracellular matrix formation in glomerulonephritis. Cell Diff Dev 2:155-162
20. Kitisawa K, Tada T 1994 Elevation of transforming growth factor β-1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 25:1400-1404
21. Tada T, Kanaji M, Kobayashi S 1994 Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β-1. J Neuroimmunol 50:153-158
22. Johnson MD, Gold LI, Moses HL 1992 Evidence for transforming growth factor-β expression in human leptomeningeal cells and transforming growth factor-β-like activity in human cerebrospinal fluid. Lab Invest 67:360-368
23. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC 1995 Release and activation of platelet latent TGF-β in blood clots during dissolution with plasma. Nature 1:932-937
24. Levene MI 1981 Measurement of the growth of the lateral ventricles in preterm infants with real time ultrasound. Arch Dis Child 56:900-904
25. Altman DG 1991 Practical Statistics for Medical Research. Chapman Hall. London, pp 189-190
26. Miyazono K, Takaku F 1989 Platelet-derived growth factors. Blood Rev 3:269-276
27. Unsicker K 1991 The role of TGF-β in the nervous system: clinical applications of TGF-β. Ciba Found Symp 157:93-97
28. Blennow M, Rosengren L, Whitelaw A 1999 Brain specific proteins: markers of periventricular white matter damage after intraventricular hemorrhage. Pediatr Res 45: 186A(abstr)